NASDAQ:CTCX Carmell (CTCX) Stock Price, News & Analysis $0.43 -0.04 (-8.45%) (As of 03:37 PM ET) Add Compare Share Share Today's Range$0.43▼$0.4950-Day Range$0.46▼$1.8352-Week Range$0.43▼$4.99Volume17,566 shsAverage Volume15,965 shsMarket Capitalization$8.95 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Carmell alerts: Email Address Carmell MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.41% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.81Based on 5 Articles This WeekInsider TradingAcquiring Shares$8,108 Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.16 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Carmell.Read more about Carmell's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.41% of the float of Carmell has been sold short.Short Interest Ratio / Days to CoverCarmell has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Carmell has recently decreased by 5.46%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCarmell does not currently pay a dividend.Dividend GrowthCarmell does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CTCX. Previous Next 3.2 News and Social Media Coverage News SentimentCarmell has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Carmell this week, compared to 0 articles on an average week.Search Interest1 people have searched for CTCX on MarketBeat in the last 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Carmell insiders have bought more of their company's stock than they have sold. Specifically, they have bought $8,108.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders29.00% of the stock of Carmell is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 24.22% of the stock of Carmell is held by institutions.Read more about Carmell's insider trading history. Previous Next 0.6 Earnings and Valuation Price to Book Value per Share RatioCarmell has a P/B Ratio of 0.40. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Carmell's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Behind the MarketsIt’s over.We found a tiny company which provides the backbone for the entire $15.7 trillion AI industry... It's used by EVERY single AI company on the planet... AMD, NVIDIA, META... none of these companies could exist without this firm.Click here for the ticker >>> About Carmell Stock (NASDAQ:CTCX)Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.Read More CTCX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CTCX Stock News HeadlinesSeptember 11, 2024 | americanbankingnews.comPAVmed (NASDAQ:PAVM) & Carmell (NASDAQ:CTCX) Head to Head ComparisonSeptember 8, 2024 | americanbankingnews.comIntegra LifeSciences (NASDAQ:IART) vs. Carmell (NASDAQ:CTCX) Financial AnalysisSeptember 16, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.September 5, 2024 | markets.businessinsider.comCarmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports CommunityJuly 31, 2024 | investing.comCarmell Corporation names Kendra Bracken-Ferguson as new CEOJuly 29, 2024 | globenewswire.comCarmell Corporation Appoints New CEO Following Addition to the Russell Microcap IndexMay 25, 2024 | finance.yahoo.comCarmell Corporation (CTCX)May 16, 2024 | investorplace.comCTCX Stock Earnings: Carmell Therapeutics Reported Results for Q4 2023September 16, 2024 | Behind the Markets (Ad)⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.May 16, 2024 | investorplace.comCTCX Stock Earnings: Carmell Therapeutics Reported Results for Q1 2024April 11, 2024 | globenewswire.comCarmell Announces Successful Closing of $3.0 Million Private PlacementApril 4, 2024 | globenewswire.comCarmell Announces $3.0 Million Private PlacementMarch 27, 2024 | globenewswire.comCarmell Announces Successful Closing of Axolotl Biologix Sale TransactionMarch 22, 2024 | investing.comCarmell Corporation divests subsidiary to focus on skincareMarch 20, 2024 | globenewswire.comCarmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix SubsidiaryMarch 18, 2024 | globenewswire.comCarmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics FieldFebruary 28, 2024 | morningstar.comCarmell Corp Ordinary Shares - Class AFebruary 26, 2024 | msn.comWhy Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionSee More Headlines Receive CTCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Carmell and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2024Today9/16/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:CTCX CUSIPN/A CIK1842939 Webwww.carmellrx.com Phone412-894-8248FaxN/AEmployees14Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,440,000.00 Net MarginsN/A Pretax Margin-132,707.41% Return on Equity-148.47% Return on Assets-40.47% Debt Debt-to-Equity RatioN/A Current Ratio0.71 Quick Ratio0.69 Sales & Book Value Annual Sales$12,320.00 Price / Sales793.62 Cash FlowN/A Price / Cash FlowN/A Book Value$1.07 per share Price / Book0.44Miscellaneous Outstanding Shares20,803,000Free Float14,770,000Market Cap$9.78 million OptionableNot Optionable Beta0.34 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Rajiv Sarman Shukla (Age 49)Executive Chairman & CEO Comp: $292.19kMr. Bryan J. Cassaday (Age 55)Chief Financial Officer Comp: $261.7kDr. Phil Campbell Ph.D.Founder and Chief Scientific OfficerDr. Lee Weiss Ph.D.FounderDr. James Burgess M.D.FounderKey CompetitorselectroCoreNASDAQ:ECORIRIDEXNASDAQ:IRIXSurgePaysNASDAQ:SURGPrecision OpticsNASDAQ:POCIAllurion TechnologiesNYSE:ALURView All CompetitorsInsiders & InstitutionsBryan J CassadayBought 475 shares on 9/10/2024Total: $218.50 ($0.46/share)Kathryn GregoryBought 1,260 shares on 9/6/2024Total: $642.60 ($0.51/share)Scott M FrischBought 87 shares on 8/30/2024Total: $49.59 ($0.57/share)Bryan J CassadayBought 1,000 shares on 8/29/2024Total: $570.00 ($0.57/share)Patrick A SturgeonBought 970 shares on 8/28/2024Total: $543.20 ($0.56/share)View All Insider TransactionsView All Institutional Transactions CTCX Stock Analysis - Frequently Asked Questions How have CTCX shares performed this year? Carmell's stock was trading at $3.81 on January 1st, 2024. Since then, CTCX stock has decreased by 88.7% and is now trading at $0.4303. View the best growth stocks for 2024 here. How were Carmell's earnings last quarter? Carmell Co. (NASDAQ:CTCX) posted its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.16) EPS for the quarter. The business had revenue of $0.01 million for the quarter. Who are Carmell's major shareholders? Top institutional investors of Carmell include Warberg Asset Management LLC (0.22%). Insiders that own company stock include Rajiv Shukla, Kathryn Gregory, Patrick A Sturgeon, Richard A Upton, Scott M Frisch, Gilles Spenlehauer, Bryan J Cassaday and Randolph W Hubbell. View institutional ownership trends. How do I buy shares of Carmell? Shares of CTCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CTCX) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carmell Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carmell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
